Form 4 Blackstone Private Real For: Sep 23 Filed by: Blackstone Holdings I/II GP L.L.C.
http://archive.fast-edgar.com/20260924/AP2TT22DL222E262222I2CY2A5NSZ222Y282
Filed on: September 24, 2026
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: LAV Fund VI, L.P.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Huang Ying
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4 Blackstone Private Real For: Sep 23 Filed by: Blackstone Private Credit Strategies LLC
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: TAGLIAFERRI MARY
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
More SEC Filings
View Older Stories-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Ackles Robert William
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Chimovits Erez
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Zhu Rui (NMN)
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: MacLeod Alan Robert
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Fisk Ryan
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: GORDON CARL L
-
Form 3 ADARx Pharmaceuticals, For: Sep 24 Filed by: Li Zhen
-
Form SCHEDULE 13D/A TORM plc Filed by: Oaktree Capital Holdings, LLC
-
Form 4 Apple Inc. For: Sep 22 Filed by: Newstead Jennifer
-
Form SCHEDULE 13G/A Jaguar Health, Inc. Filed by: Mailman Joshua
-
Form SCHEDULE 13D/A Xanadu Quantum Technolog Filed by: Weedbrook Christian
-
Form 4 Grupo Cibest S.A. For: Sep 21 Filed by: Vatnick Silvina
-
Form 3 Coursera, Inc. For: Sep 21 Filed by: Savage Thomas I.
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: Conen Ziv
-
Form 4 ONEOK INC /NEW/ For: Sep 23 Filed by: SPEARS MARY M
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: Seideman Harrison T.
-
Form 4 IMPINJ INC For: Sep 23 Filed by: DIORIO CHRIS PH.D.
-
Form 4 ONEOK INC /NEW/ For: Sep 23 Filed by: HULSE WALTER S III
-
Form 4 Grupo Cibest S.A. For: Sep 21 Filed by: Vatnick Silvina
-
Form 4 ONEOK INC /NEW/ For: Sep 23 Filed by: SWORDS SHERIDAN C
-
Form 4 IMPINJ INC For: Sep 23 Filed by: Baker Cary
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: Bradley Christopher
-
Form 4 ONEOK INC /NEW/ For: Sep 23 Filed by: Taylor Lyndon C
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: Weksler Andrew P.
-
Form 4 Rush Street Interactive, For: Sep 22 Filed by: BLUHM NEIL
-
Form SCHEDULE 13D/A Blackstone Private Real Filed by: Blackstone Holdings I/II GP L.L.C.
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: Vohs Christopher J.
-
Form SCHEDULE 13D/A Vertical Aerospace Ltd. Filed by: Mudrick Capital Management, L.P.
-
Form 4 ONEOK INC /NEW/ For: Sep 23 Filed by: BURDICK KEVIN L
-
Form 3 Bluerock Acquisition For: Sep 24 Filed by: KAMFAR RAMIN
-
Form 4 Revolution Medicines, For: Sep 22 Filed by: ANDERSON ELIZABETH M
-
Form 4 Snowflake Inc. For: Sep 23 Filed by: Dageville Benoit
-
Form 4 Capitol Federal Financia For: Sep 23 Filed by: Skrobacz William Joseph Jr
-
Form 4 Snowflake Inc. For: Sep 23 Filed by: Beaulier Jonathan Mead
-
Form 4 Butterfly Network, Inc. For: Sep 22 Filed by: DEVIVO JOSEPH
-
Form 4 Park Hotels & Resorts For: Sep 23 Filed by: NAUGHTON TIMOTHY J
-
Form 4 Park Hotels & Resorts For: Sep 23 Filed by: Bedient Patricia M
-
Form 4 Park Hotels & Resorts For: Sep 23 Filed by: NATELLI THOMAS A
-
Form 144 Twist Bioscience Corp Filed by: Leproust Emily M.
-
Form 3 Kontoor Brands, Inc. For: Sep 23 Filed by: Caulfield James T.
-
Form SCHEDULE 13G Private Bancorp of Ameri Filed by: RADY ERNEST S
-
Form SCHEDULE 13D/A PRIMEENERGY RESOURCES Filed by: HURT CLINT
-
Form 4 ALASKA AIR GROUP, INC. For: Sep 23 Filed by: Berry Jason M
-
Form 4 ALASKA AIR GROUP, INC. For: Sep 22 Filed by: SCHNEIDER ANDREA L
-
Form 4 TechTarget, Inc. For: Sep 22 Filed by: Noreck Daniel T
-
Form 4 TechTarget, Inc. For: Sep 22 Filed by: Morelli William Thomas
-
Form 4 TechTarget, Inc. For: Sep 22 Filed by: Niemiec Steven
-
Form 4 CRISPR Therapeutics AG For: Sep 22 Filed by: KASINGER JAMES R.
-
Form 4 TechTarget, Inc. For: Sep 22 Filed by: Rennick Charles D
-
Form 4 TechTarget, Inc. For: Sep 22 Filed by: Nugent Gary John
